Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
CVS Health
CVS
|
$747M |
| 2 |
Bank of America
BAC
|
$668M |
| 3 |
Truist Financial
TFC
|
$648M |
| 4 |
VF Corp
VFC
|
$567M |
| 5 |
Fidelity National Information Services
FIS
|
$491M |
Top Sells
| 1 |
VMW
VMware, Inc
VMW
|
$1.05B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$644M |
| 3 |
Capital One
COF
|
$613M |
| 4 |
Cisco
CSCO
|
$608M |
| 5 |
UBS Group
UBS
|
$455M |
Sector Composition
| 1 | Financials | 20.65% |
| 2 | Healthcare | 19.58% |
| 3 | Technology | 15.74% |
| 4 | Communication Services | 12.93% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.95B | 1.32% | 2,372,998 -21,357 | -0.9% | -$17.6M |
|
|
27
CVS Health
CVS
$92.8B
| $1.87B | 1.26% | 26,722,982 +10,698,560 | +67% | +$747M |
|
|
28
Bank of America
BAC
$376B
| $1.82B | 1.23% | 66,637,135 +24,411,655 | +58% | +$668M |
|
29
Goldman Sachs
GS
$226B
| $1.79B | 1.21% | 5,541,257 -61,228 | -1% | -$19.8M |
|
30
AB InBev
BUD
$122B
| $1.76B | 1.19% | 31,844,538 +6,558,810 | +26% | +$363M |
|
31
UnitedHealth
UNH
$281B
| $1.74B | 1.17% | 3,447,190 +420 | +0% | +$212K |
|
32
Novartis
NVS
$245B
| $1.66B | 1.12% | 16,264,221 -142,892 | -0.9% | -$14.6M |
|
|
33
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.63B | 1.1% | 12,428,035 -45,875 | -0.4% | -$6M |
|
34
ConocoPhillips
COP
$124B
| $1.61B | 1.08% | 13,430,859 -238,742 | -2% | -$28.6M |
|
35
T-Mobile US
TMUS
$284B
| $1.59B | 1.07% | 11,364,708 -142,240 | -1% | -$19.9M |
|
|
36
Cisco
CSCO
$274B
| $1.55B | 1.04% | 28,779,116 -11,305,908 | -28% | -$608M |
|
37
Suncor Energy
SU
$50.1B
| $1.54B | 1.04% | 44,879,454 -150,600 | -0.3% | -$5.18M |
|
38
LyondellBasell Industries
LYB
$18.1B
| $1.54B | 1.04% | 16,219,492 -156,800 | -1% | -$14.8M |
|
|
39
Truist Financial
TFC
$60.4B
| $1.52B | 1.02% | 53,051,950 +22,660,216 | +75% | +$648M |
|
40
Baker Hughes
BKR
$44.8B
| $1.51B | 1.01% | 42,635,774 -1,244,880 | -3% | -$44M |
|
41
Alibaba
BABA
$322B
| $1.4B | 0.94% | 16,091,470 +1,493,300 | +10% | +$130M |
|
42
Honda
HMC
$44.4B
| $1.39B | 0.94% | 41,324,800 -2,903,975 | -7% | -$97.7M |
|
43
State Street
STT
$32.6B
| $1.38B | 0.93% | 20,641,269 -1,084,205 | -5% | -$72.6M |
|
44
Microchip Technology
MCHP
$35.1B
| $1.35B | 0.91% | 17,303,884 -4,451,984 | -20% | -$347M |
|
45
Ovintiv
OVV
$10.8B
| $1.35B | 0.91% | 28,307,076 -1,053,200 | -4% | -$50.1M |
|
46
Meta Platforms (Facebook)
META
$1.86T
| $1.33B | 0.9% | 4,426,613 -150,881 | -3% | -$45.3M |
|
47
Cognizant
CTSH
$35.3B
| $1.32B | 0.89% | 19,466,697 -174,050 | -0.9% | -$11.8M |
|
48
Williams Companies
WMB
$70.7B
| $1.29B | 0.87% | 38,343,057 -671,049 | -2% | -$22.6M |
|
49
Norfolk Southern
NSC
$62.8B
| $1.26B | 0.85% | 6,422,714 +2,116,575 | +49% | +$417M |
|
50
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.25B | 0.84% | 14,153,503 -136,800 | -1% | -$12.1M |
|